[Insightec in Asian Hospital and Healthcare Management] Insightec announces FDA approval of Exablate Neuro for the treatment of Parkinson’s Disease

Insightec®, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy, announced today that the U.S. Food and Drug Administration (FDA) has approved the Exablate® Neuro for treating advanced Parkinson’s Disease patients suffering from mobility, rigidity, or dyskinesia symptoms.

Read more here.

Source: https://blog.ourcrowd.com/insightec-announces-fda-approval-of-exablate-neuro-for-the-treatment-of-parkinsons-disease-2/